Elevance Health Q2 Adj. EPS $9.04 Beats $8.80 Estimate, Sales $43.38B Beat $41.50B Estimate
Portfolio Pulse from Benzinga Newsdesk
Elevance Health (NYSE:ELV) reported Q2 earnings of $9.04 per share, beating the analyst consensus estimate of $8.80 by 2.73%. This is a 13.43% increase from the same period last year. The company also reported quarterly sales of $43.38 billion, beating the analyst consensus estimate of $41.50 billion by 4.52%. This is a 12.72% increase from the same period last year.
July 19, 2023 | 10:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Elevance Health's Q2 earnings and sales exceeded estimates, indicating a strong financial performance. This could potentially lead to a positive short-term impact on the company's stock.
Elevance Health's Q2 earnings and sales have exceeded the analyst consensus estimates, indicating a strong financial performance. This positive news could potentially lead to an increase in investor confidence and a positive short-term impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100